Surgery Partners to be acquired by Bon Secours for $5.7B

What happened

Surgery Partners has agreed to be acquired by HealthSpan Partners, a contractual affiliate of Bon Secours Mercy Health, in an all-cash deal worth $5.7B. Shareholders other than Bain Capital affiliates will get $23.50 per share, but the deal is not yet final and awaits approval.

Proposed

Global impact / market context

If completed, Surgery Partners would leave the Nasdaq and become privately held while keeping its name, brand, and headquarters. Public investors would receive cash instead of shares, so their return would depend on the deal closing rather than future stock trading.

Analyst inference

Bain Capital owns about 39% of shares and has agreed to vote in favor, which makes approval more likely but not certain. The expected first-quarter 2027 close still depends on shareholder and regulatory approvals, so the transaction remains conditional.

Analyst inference

What to watch

1. Watch whether Surgery Partners shareholders approve the transaction, since the deal cannot close without their vote. Confirmed
2. Watch whether regulators grant the required approvals and whether other customary closing conditions are met before the expected first-quarter 2027 close. Proposed
3. Watch how Bain Capital's roughly 39% stake and its voting support agreement affect the outcome, because its backing could influence the shareholder vote. Analyst inference

Evidence

• seekingalpha.com